This brief is 100% free to read. No login required.

Evidence verified against 2024-2025 systematic reviews

Parkinson'sModerate evidenceSystematic Review and Randomized Controlled Trial 2026 High-Standard

Progressive Resistance Training for Bradykinesia in Parkinson's

This brief summarizes the evidence for using progressive resistance training (PRT) to manage bradykinesia in patients with mild to moderate Parkinson's disease. It provides a practical, evidence-based protocol that clinicians can implement to improve motor symptoms and functional performance.

Research: March 2023

Key Findings

1PRT significantly improves bradykinesia in patients with mild to moderate Parkinson's disease.
2A 9-week, twice-weekly PRT program can lead to significant improvements in functional performance.
3PRT has positive effects on freezing of gait, muscle strength, and quality of life.
4The PRT protocol includes exercises targeting major muscle groups: chest press, knee extension, hamstring curl, leg press, and seated row.
5Progression is key: increase the weight when the patient can perform more than 12 repetitions.

Bradykinesia is a real challenge for our patients with Parkinson's, and we're always looking for effective ways to manage it. A growing body of evidence suggests that progressive resistance training (PRT) can be a powerful tool. This comes from a 2023 systematic review of 14 studies, including 761 patients, which found that PRT has positive effects on freezing of gait, muscle strength, and quality of life. A 2020 randomized controlled trial with 40 participants (Hoehn & Yahr stages 1-3) provides a specific, practical protocol. The study found that a 9-week PRT program, performed twice a week, significantly improved bradykinesia and functional performance. The protocol is straightforward and can be adapted for most clinical settings. It consists of 2 sets of 10-12 repetitions to fatigue on five key exercises: chest press, knee extension, hamstring curl, leg press, and seated row. The key is 'progressive' overload – once a patient can complete more than 12 repetitions, it's time to increase the weight. Each session lasts about 50-60 minutes. While this study didn't show a significant increase in isokinetic muscle strength, the improvements in functional tests like the Timed Up and Go and 30-Second Chair Stand are what really matter for our patients' daily lives.

Clinician's Note

I've found that patients are more likely to stick with this program if they understand the 'why' behind it. I always take the time to explain how building strength can help them move more easily and feel more in control. It's also important to manage expectations. This isn't a quick fix, but with consistent effort, they can see real improvements in their daily lives. I also make sure to celebrate the small wins along the way to keep them motivated.

Clinic Action Plan

1. Screen for appropriateness: This protocol is for patients with mild to moderate Parkinson's disease (Hoehn & Yahr stages 1-3). 2. Familiarize the patient: Spend 2-3 sessions on proper form and technique for each exercise. 3. Implement the protocol: 2 sets of 10-12 repetitions to fatigue, twice a week, for 9 weeks. 4. Focus on progression: Once the patient can perform more than 12 repetitions, increase the weight. 5. Monitor for safety: Supervise sessions to ensure proper form and prevent injuries. 6. Track progress: Use functional outcome measures like the Timed Up and Go and 30-Second Chair Stand to track progress. 7. Educate the patient: Explain the importance of consistency and long-term adherence to the program.

Common Mistakes to Avoid

•Not progressing the resistance: The 'progressive' part of PRT is crucial for seeing results.
•Focusing only on strength numbers: The goal is to improve function, not just lift heavier weights.
•Neglecting proper form: Poor form can lead to injury and limit the effectiveness of the exercises.
•Not providing enough supervision: Especially in the beginning, patients need guidance to ensure they are performing the exercises correctly and safely.

Frequently Asked Questions

Premium Deep Dive

This brief includes an extended deep-dive section with clinical nuance, dosing details, edge cases, and special population considerations.

Unlock with Premium — $99/yr

Meets 2026 NeuroDash High-Standard Criteria

This brief passes all 6 mandatory quality criteria: objective outcome measures, 5+ DOI-linked sources from top-tier institutions, GRADE evidence rating, specific dosing parameters, 3+ recent (2023–2026) citations, and a step-by-step Clinic Action Plan.

Last verified April 21, 2026 Based on 2023–2026 systematic reviews All outcome measures are quantifiable

View the 2026 Research Quality Master Criteria

GRADE-graded with DOI links Evidence verified

This brief is for educational purposes only. Always verify clinical decisions with peer-reviewed sources and your professional judgment.

Want more from NeuroDash?

Save protocols, track CEU hours, download PDFs, and get unlimited AI access.

Explore Premium — $99/yr

More in Parkinson's

Boxing-Based Exercise Programs for Parkinson's Disease

This brief explores the evidence behind non-contact boxing for patients with Parkinson's disease, covering its impact on motor and non-motor symptoms. It provides practical guidance on implementing these programs in a clinical setting.

Argentine Tango for Parkinson's: A Rhythmic Approach to Improving Motor Control

This brief explores the use of Argentine Tango as a therapeutic intervention for patients with Parkinson's Disease. We'll delve into the evidence supporting its benefits for motor symptoms, balance, and gait, providing you with practical guidance on how to incorporate it into your treatment plans.

Unlocking Potential: A Practical Guide to Dual-Task Training for Parkinson's Disease

This brief explores the evidence and practical application of dual-task training (DTT) to improve cognitive-motor interference in patients with Parkinson's disease. Discover how to implement DTT to enhance gait, balance, and overall function in your patients.

High-Intensity Treadmill Exercise: A Potential Neuroprotective Therapy for Early Parkinson's Disease

This brief explores the potential of high-intensity treadmill exercise (80-85% HRmax) to slow the progression of early Parkinson's disease. We delve into the protocol of the ongoing SPARX3 Phase 3 clinical trial, examining the specific exercise 'dose' being tested and the key outcomes, including motor scores and objective biomarker evidence. This research could establish exercise as the first disease-modifying therapy for Parkinson's.

Related Videos